Photoplethysmography Biosensors Market Size
Photoplethysmography Biosensors Market size was valued at USD 423.1 million in 2022 and is projected to reach at USD 1.2 billion by 2032. Photoplethysmography (PPG) biosensors are devices that utilize the technique of photoplethysmography to measure changes in blood volume in peripheral blood vessels.

PPG is a non-invasive optical method that provides information about the pulsatile component of blood flow. It involves illuminating the skin with a light source, usually a light-emitting diode (LED), and detecting the reflected or transmitted light using a photodetector. Moreover, advancements in sensor technology, miniaturization and low-power electronics have contributed to the development of PPG biosensors. These advancements have led to the integration of PPG sensors into smaller, wearable medical devices that offer improved accuracy, reliability, and battery life.
As heart disease becomes more common, so does the demand for this technology. In 2022 alone, nearly 700,000 people in the US died from cardiovascular disease. Advancements in this area, combined with new technologies, help detect heart problems faster and provide better care remotely. This can help reduce the number of people dying from heart disease. Plus, this technique is less expensive and easier to use than traditional heart-monitoring methods like electrocardiograms (ECGs). It can measure your heart rate and other signals from various body parts, like your fingers, toes, ears, wrists, chest, and head.
Photoplethysmography (PPG) Biosensors Market Report Attributes
Report Attribute |
Details |
Base Year | 2022 |
---|
Photoplethysmography (PPG) Biosensors Market Size in 2022 | USD 423.1 Million |
---|
Forecast Period | 2023 to 2032 |
---|
Forecast Period 2023 to 2032 CAGR | 10.8% |
---|
2032 Value Projection | USD 1.2 Billion |
---|
Historical Data for | 2018 to 2022 |
---|
No. of Pages | 175 |
---|
Tables, Charts & Figures | 204 |
Segments covered | Product, Application, and Region |
---|
Growth Drivers | - Increasing demand for smart wearables incorporated with PPG biosensors
- Rising awareness regarding health monitoring
- Global increase in prevalence of cardiovascular diseases
- The advancement in technology and the non-invasive nature of PPG biosensors
|
---|
Pitfalls & Challenges | - Several disadvantages over ECG sensors
- High cost of product development
|
---|
COVID-19 Impact
Hey there! The pandemic turned the healthcare world upside down, especially for folks using PPG biosensors. With everyone trying to stay apart and hospitals getting slammed, there was a huge need for ways to keep an eye on patients from afar. That's where PPG biosensors really stepped up, particularly the ones built into smartwatches and fitness trackers. These little gadgets let people track their heart rate, oxygen levels, and other vital stats right from their couch. This meant that people could catch early signs of COVID-19 or keep an eye on their existing health issues without having to leave the house. It was like having a mini-doctor at their fingertips, making things a lot easier during those tough times.
Photoplethysmography Biosensors Market Trends
Smart wearables with PPG biosensors offer users the ability to monitor their heart rate, blood oxygen saturation, and other vital signs continuously. This real-time monitoring allows individuals to track their health and fitness levels, optimize their workout, and make informed decisions about their well-being. Additionally, PPG-based wearables provide valuable insights into heart rate variability, sleep patterns, stress levels, and exercise performance, empowering users to take control of their health and make positive lifestyle changes.
Moreover, the rise of telemedicine and remote patient monitoring further enhanced the demand for smart wearables with PPG biosensors. Remote monitoring using PPG wearables is particularly beneficial for patients with chronic conditions, allowing early detection of anomalies, timely intervention, and improved disease management.
Photoplethysmography Biosensors Market Analysis
Based on product, the PPG biosensors market is segmented into pulse oximeters, smart watches, smart wrist bands and others. The smart watches segment witnessed the largest revenue size of USD 170.3 million in 2022. PPG biosensors are extensively used in smartwatches to track user medical conditions during sleep, sports, and daily activities. The Consumer Technology Association estimates that 20.1 million smartwatches were sold in the U.S. in 2021. The bulk of these items includes the Fitbit, Apple Watch, Garmin, and numerous other smartwatches, that contain photoplethysmography-based heart rate monitors.

The market for devices that use photoplethysmography (PPG) to track heart rate, blood oxygen levels, blood pressure, and other health metrics is segmented into different categories. Among these, the heart rate monitoring segment is expected to be the biggest, with a market value of about $459.4 million by 2032. PPG biosensors are commonly found in smartwatches and fitness trackers that can measure your heart rate. They're also used in other health devices. Heart disease is a big problem around the world. In the United States alone, more than 122 million adults had heart disease in 2022. This includes conditions like heart attacks, strokes, and heart failure. Devices like those that use PPG biosensors can help people monitor their heart health and manage their risk of heart disease. This is becoming increasingly important as people take more control of their own health.

U.S. photoplethysmography biosensors market accounted for USD 143.9 million in 2022. Growing adoption of wearable health monitoring devices across the nation is one of the major factors accelerating business demand. Moreover, increasing prevalence of chronic disease ailments such as cardiovascular diseases, diabetes, and respiratory disorders has led to higher adoption of PPG biosensors based medical devices for early detection and disease management with real time data access and vital signs monitoring. Furthermore, strong presence of leading industry players in the country involved in development of innovative products with advanced technologies will boost customer preference.
Photoplethysmography Biosensors Market Share
Some of the notable key market participants operating in the photoplethysmography biosensors market include
- Apple Inc
- Fitbit Inc
- Samsung Electronics Co., Ltd.
- Garmin Ltd
- Xiaomi Corporation
- Omron Healthcare, Inc.
- Valencell. Inc
- Mediatek
- Masimo Corporation
- Empatica Inc
Photoplethysmography Biosensors Industry News
- In August 2020, Valencell introduced the world's first calibration-free blood pressure (BP) sensor technology for use in wearables as well as worn on the finger and wrist. PPG and inertial sensors are used in this technology. Development of such technologies help companies in sustaining their market position as well as gain competitive edge over others in the market.
PPG biosensors market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Product (USD Million)
- Pulse oximeters
- Smart watches
- Smart wrist bands
- Others
By Application (USD Million)
- Heart rate monitoring
- Blood-oxygen saturation
- Blood pressure
- Others
The above information is provided for the following regions and countries
- North America
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Poland
- Switzerland
- Norway
- Finland
- Sweden
- Denmark
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Taiwan
- Indonesia
- Vietnam
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Chile
- Middle East & Africa
- Saudi Arabia
- South Africa
- UAE
- Israel